tirzepatide class of drug What Is Used for? Approved and Potential Uses TrimRX | Starting Dose of

Tirzepatide is a dual GLP-1/GIP receptor agonist, activating both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors simultaneously

In fact, the largest weight loss trials for all three medications were conducted in people without diabetes

There is no coaching, nutrition program, or fitness layer

These findings are currently being translated into human studies, offering hope for new therapeutic strategies against cognitive decline and other neurological disorders

[DOI] [PubMed] [Google Scholar] 5.Dose-dependent efficacy and safety of tirzepatide for weight loss in non-diabetic adults with obesity: a systematic review and meta-analysis of randomized controlled trials